Estrogen-induced small low-density lipoprotein particles in postmenopausal women
- PMID: 9469282
- DOI: 10.1016/s0029-7844(97)00651-0
Estrogen-induced small low-density lipoprotein particles in postmenopausal women
Abstract
Objective: To investigate the mechanisms of an estrogen-induced decrease in the size of low-density lipoprotein (LDL) particles in postmenopausal women.
Methods: Twenty postmenopausal women were treated with conjugated equine estrogen, 0.625 mg daily, for 3 months. Plasma levels of total cholesterol, triglyceride, high-density lipoprotein (HDL) cholesterol, and apolipoproteins AI, AII, and B were measured before and after therapy. We analyzed total, free, and esterified cholesterol, triglyceride, phospholipid, and apolipoprotein B levels in the LDL. Cholesterol, triglyceride, and phospholipid concentrations were measured by enzymatic methods. Apolipoprotein AI, AII, and B levels were determined by immunoturbidimetric assay. The diameter of LDL particles was determined by gradient gel electrophoresis.
Results: Estrogen reduced significantly the plasma levels of total cholesterol and apolipoprotein B and increased significantly the plasma levels of triglyceride, HDL cholesterol, and apolipoproteins AI and AII. The ratio of cholesteryl ester to apolipoprotein B was significantly reduced, whereas the ratio of triglyceride to apolipoprotein B was significantly increased after such treatment. The plasma level of triglyceride showed a positive correlation with the ratio of LDL-triglyceride/apolipoprotein B (r = .40, P < .01), and a negative correlation with the ratio of LDL-cholesteryl ester/apolipoprotein B (r = -.55, P < .001). Estrogen treatment reduced significantly the diameter of LDL particles (25.79+/-1.13 nm versus 24.94+/-1.02 nm, P < .001). The diameter of the LDL particle was correlated negatively with the plasma level of triglyceride (r = -.84, P < .001) and the ratio of LDL-triglyceride/apolipoprotein B (r = -.58, P < .001), and positively with the ratio of LDL-cholesteryl ester/apolipoprotein B (r = .57, P < .001).
Conclusion: The results of this study indicate that an increase in the triglyceride plasma level induced by estrogen therapy appeared to produce small triglyceride-rich and cholesteryl ester-poor LDL particles that were of small size.
Similar articles
-
Lipid transfer reactions and lipid composition of low-density lipoprotein particles in postmenopausal women receiving estrogen.Obstet Gynecol. 1999 Oct;94(4):492-7. doi: 10.1016/s0029-7844(99)00391-9. Obstet Gynecol. 1999. PMID: 10511347
-
Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.Obstet Gynecol. 1997 Jul;90(1):22-5. doi: 10.1016/S0029-7844(97)00140-3. Obstet Gynecol. 1997. PMID: 9207806
-
Lipolytic enzyme effect on small low-density lipoprotein particles in women treated with estrogen.Obstet Gynecol. 2001 Mar;97(3):333-7. doi: 10.1016/s0029-7844(00)01185-6. Obstet Gynecol. 2001. PMID: 11239632
-
Atherogenic lipoprotein particles in atherosclerosis.Circulation. 2004 Jun 15;109(23 Suppl 1):III2-7. doi: 10.1161/01.CIR.0000131511.50734.44. Circulation. 2004. PMID: 15198959 Review.
-
Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.Curr Atheroscler Rep. 2000 May;2(3):200-7. doi: 10.1007/s11883-000-0021-4. Curr Atheroscler Rep. 2000. PMID: 11122745 Review.
Cited by
-
Hepatic Effects of Estrogen on Plasma Distribution of Small Dense Low-Density Lipoprotein and Free Radical Production in Postmenopausal Women.J Atheroscler Thromb. 2016 Jul 1;23(7):810-8. doi: 10.5551/jat.33175. Epub 2016 Feb 22. J Atheroscler Thromb. 2016. PMID: 26903399 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources